Evidence map›Paper›PMID 32613737›Full record

ArticleChemMedChem2020

First-Generation Bispidine Chelators for

Frank Bruchertseifer, Peter Comba, Bodo Martin, Alfred Morgenstern, Johannes Notni, Miriam Starke, Hubert Wadepohl

Abstract read
In one paragraph

Article in ChemMedChem, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Tuning the Kinetic Inertness of BiInorganic chemistry · 2021
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Frank BruchertseiferEuropean Commission, Joint Research Centre, />Directorate for Nuclear Safety and Security, Hermann-von-Helmholtz-Platz 1, 76344, Eggenstein-Leopoldshafen, Germany.
Peter CombaUniversität Heidelberg, Anorganisch-Chemisches Institut, Neuenheimer Feld 270, 69120, Heidelberg, Germany.ORCID 0000-0001-7796-3532
Bodo MartinUniversität Heidelberg, Anorganisch-Chemisches Institut, Neuenheimer Feld 270, 69120, Heidelberg, Germany.ORCID 0000-0001-7930-0679
Alfred MorgensternEuropean Commission, Joint Research Centre, />Directorate for Nuclear Safety and Security, Hermann-von-Helmholtz-Platz 1, 76344, Eggenstein-Leopoldshafen, Germany.
Johannes NotniTechnische Universität München Institut für Pathologie und Pathologische Anatomie, Trogerstr. 18, 81675, Munich, Germany.ORCID 0000-0002-3964-3391
Miriam StarkeUniversität Heidelberg, Anorganisch-Chemisches Institut, Neuenheimer Feld 270, 69120, Heidelberg, Germany.ORCID 0000-0002-7034-5595
Hubert WadepohlUniversität Heidelberg, Anorganisch-Chemisches Institut, Neuenheimer Feld 270, 69120, Heidelberg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepta- and octadentate bispidines (3,7-diazabicyclo[3.3.1]nonane, diaza-adamantane) with acetate, methyl-pyridine, and methyl-picolinate pendant groups at the amine donors of the bispidine platform have been prepared and used to investigate Bi

Indexed as

BismuthBridged Bicyclo Compounds, HeterocyclicChelating AgentsCoordination ComplexesHydrophobic and Hydrophilic InteractionsKineticsLigandsMolecular StructureRadioisotopesRadiopharmaceuticalsTemperatureBismuthbispidineBridged Bicyclo Compounds, HeterocyclicChelating AgentsCoordination ComplexesLigandsRadioisotopesRadiopharmaceuticals

Identifiers

PMID32613737
PMCPMC7496608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.